NOV Inc. Stock
We can see a decrease in the price for NOV Inc.. Compared to yesterday it has lost -€0.180 (-1.110%).
Currently there is a rather positive sentiment for NOV Inc. with 19 Buy predictions and 5 Sell predictions.
On the other hand, the target price of 16 € is below the current price of 16.04 € for NOV Inc., so the potential is actually -0.22%.
Our community identified positive and negative aspects for NOV Inc. stock for the coming years. 1 users see the criterium "Balance Sheet Risk" as a plus for the NOV Inc. stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.
Pros and Cons of NOV Inc. in the next few years
Pros
?
M***** P*******
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
Cons
?
B****
?
S********** s********
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of NOV Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| NOV Inc. | -1.110% | -6.036% | -0.527% | 24.883% | 20.928% | -10.917% | 14.741% |
| SBM Offshore N.V. | -0.670% | 5.036% | 8.757% | 63.518% | 32.816% | 145.770% | 105.170% |
| Cimc Enric Holdings Inc. | 1.590% | 0.000% | 0.000% | 66.234% | 32.642% | 37.265% | 93.939% |
| Core Laboratories Inc. | -0.730% | 1.493% | -12.258% | 0.741% | 0.000% | -31.486% | -58.282% |
Comments
NOV (NOV) had its price target raised by The Goldman Sachs Group, Inc. from $17.00 to $20.00. They now have a "sell" rating on the stock.
Show more
Ratings data for NOV provided by MarketBeat
NOV (NYSE:NOV) had its "buy" rating reaffirmed by analysts at TD Cowen.
Show more
Ratings data for NOV provided by MarketBeat
NOV (NYSE:NOV) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada.
Show more
Ratings data for NOV provided by MarketBeat
News
This Fund Put 22% of Assets Into an Oilfield Equipment Stock Up 25% in a Year
London-based Oldfield Partners increased its stake in NOV (NYSE:NOV) by 276,961 shares in the fourth quarter, an estimated $4.11 million trade based on quarterly average pricing, according to a
